Tag: generative AI in drug discovery

As artificial intelligence continues to redefine the landscape of scientific innovation, its intersection with pharmaceutical research stands as one of ...

Cambridge, MA – March 2, 2025 – Insilico Medicine, a clinical-stage biotechnology company at the forefront of integrating generative artificial ...

In a groundbreaking announcement set to reshape the landscape of cardiometabolic therapeutics, Insilico Medicine, a clinical-stage biotechnology company propelled by ...

In a significant breakthrough that could redefine the battle against antibiotic resistance, researchers have harnessed the power of generative artificial ...

In a groundbreaking announcement that signals a new era for biotechnology and artificial intelligence, Alex Zhavoronkov, PhD, founder, CEO, and ...

In a groundbreaking study published in the prestigious journal Cell, researchers at the Massachusetts Institute of Technology (MIT) have leveraged ...

In a groundbreaking advancement at the nexus of artificial intelligence and medicinal chemistry, Insilico Medicine, in collaboration with Huadong Medicine ...

Insilico Medicine, a pioneering force in the realm of artificial intelligence-driven biotechnology, has made significant strides in the battle against ...

Harbour BioMed and Insilico Medicine have forged a strategic alliance that aims to revolutionize the landscape of antibody discovery and ...